NCT02988050

Brief Summary

Sixty patients were randomly allocated into two groups, group PD and group PR, thirty patients in each group. Patients in PD group received propofol and dexmedetomidine intravenous infusion and patients in PR group received propofol and remifentanil intravenous infusion. Sedation score and patients' satisfaction, surgeon satisfaction, heart rate, mean arterial blood pressure, oxygen saturation, and side effects such as respiratory depression, nausea, vomiting, airway obstruction, and oxygen desaturation were recorded.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2013

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 9, 2016

Completed
3.8 years until next milestone

Results Posted

Study results publicly available

October 9, 2020

Completed
Last Updated

October 9, 2020

Status Verified

September 1, 2020

Enrollment Period

2.5 years

First QC Date

November 28, 2016

Results QC Date

August 10, 2020

Last Update Submit

September 16, 2020

Conditions

Keywords

Epilepsy SurgeryConscious sedation

Outcome Measures

Primary Outcomes (1)

  • Patients Satisfaction

    Patient's satisfaction was recorded using a score ranging from 0 for not satisfied to 10 for totally satisfied.

    1 hour after the operation

Study Arms (2)

Propofol-dexmedetomidine

OTHER

Propofol-dexmedetomidine Bupivacaine; Lidocaine (local anaesthetics) Epinephrine (with local anaesthetics for skin infiltration)

Drug: DexmedetomidineDrug: PropofolDrug: BupivacaineDrug: LidocaineDrug: Epinephrine

Propofol-remifentanil

OTHER

Propofol-remifentanil Bupivacaine; Lidocaine Epinephrine (with local anaesthetics for skin infiltration)

Drug: RemifentanilDrug: PropofolDrug: BupivacaineDrug: LidocaineDrug: Epinephrine

Interventions

Remifentanil used for conscious sedation.

Propofol-remifentanil

Dexmedetomidine used for conscious sedation.

Propofol-dexmedetomidine

Used for conscious sedation.

Propofol-dexmedetomidinePropofol-remifentanil

Local anaesthetics

Propofol-dexmedetomidinePropofol-remifentanil

Local anaesthetic

Propofol-dexmedetomidinePropofol-remifentanil

With local anaesthetic for skin infiltration.

Propofol-dexmedetomidinePropofol-remifentanil

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients require conscious sedation for epilepsy surgery

You may not qualify if:

  • Patients refusal, allergy to drugs used, and uncooperative patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Epilepsy

Interventions

RemifentanilDexmedetomidinePropofolBupivacaineLidocaineEpinephrine

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

PropionatesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsImidazolesAzolesPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsAnilidesAmidesAniline CompoundsAminesAcetanilidesEthanolaminesAmino AlcoholsAlcoholsBiogenic MonoaminesBiogenic AminesCatecholaminesCatechols

Results Point of Contact

Title
Professor Ezzeldin Ibrahim, Professor of Anaesthesia
Organization
Menoufia University

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor in anaesthesia, intensive care, and pain medicine

Study Record Dates

First Submitted

November 28, 2016

First Posted

December 9, 2016

Study Start

August 1, 2013

Primary Completion

February 1, 2016

Study Completion

April 1, 2016

Last Updated

October 9, 2020

Results First Posted

October 9, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share